posted on 2022-05-10, 14:11authored byBailey
F. McCarthy Riley, Hao T. Mai, Thomas H. Linz
Lipid nanoparticles serve as drug
delivery vehicles for biopharmaceutical
products. The lipid membrane shields internal nucleic-acid drug cargo
from enzymatic degradation and facilitates cellular uptake of the
drug. However, existing methods to assess drug loading within liposomes
are limited to averaged bulk measurements, which obscures heterogeneity
of the biopharmaceutical formulation. This report describes the development
of a single-liposome analysis method to measure copy numbers of DNA
within liposomes and assess population heterogeneity. This novel measurement
was achieved by integrating two orthogonal polymerase chain reaction
(PCR) techniquesdigital PCR (dPCR) and quantitative PCR (qPCR)within
a single microfluidic assay. The dPCR dimension quantified liposomes
to validate their capture in the single-liposome analysis regime.
The qPCR dimension quantified DNA copy numbers packaged within each
liposome. The ability of digital quantitative PCR (dqPCR) to analyze
large numbers of individual liposomes in parallel revealed significant
population heterogeneity, which could not be obtained from standard
bulk analysis methods. Our innovative measurement of internal DNA
cargo from single liposomes has the potential to inform liposome synthesis
procedures and create more uniform liposomal biopharmaceutical formulations
to enhance drug safety and efficacy.